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Effect of metabolic acidosis on the expression of insulin-like growth
factor and growth hormone receptor. To further our understanding of
the growth failure in metabolic acidosis, we examined the insulin-like
growth factor (IGF-1 and IGF-II), the IGF binding protein-3 (IGFBP-3),
and the hepatic IGF mRNA and growth hormone receptor mRNA in
control, pair-fed and acidotic rats. The rats in the last group were made
acidotic by using ammonium chloride (1.5%) as their sole fluid intake
for eight days. Metabolic acidosis was confirmed by a blood pH of 7.11
0.10 (mean SD). The mean starting weights for all rats were 167.1
3.4 grams. Growth impairment was observed in the acidotic rats after
one week of ammonium chloride intake. The body weights of the
acidotic rats compared to those of the control rats were 155.5 18.9 g
versus 222.8 9.7 g, P < 0.001; the pair-fed rats weighed 156.8 19.6
grams. All rats were bled and sacrificed on day 8. Sera and tissue were
analyzed with the following results: compared to the ad libitum con-
trols, the same IGF-I concentrations were significantly decreased in the
acidotic animals (P < 0.02) as well as pair-fed controls (P < 0.005). The
serum IGF-II and IGF-binding protein-3 concentrations were un-
changed by acidosis or food restriction. The hepatic IGF-1 mRNA was
significantly reduced by acidosis (P < 0.01) and pair-feeding (P < 0,01).
Compared to control, the mean hepatic IGF mRNA in acidosis was
significantly lower (P < 0.01). However, there was no significant
difference between the acidotic and the pair-fed groups. The growth
hormone receptor mRNA was depressed in acidosis (P < 0.02), but the
data in the pair-fed group did not differ significantly from that of the
control group. We conclude that the growth retardation of metabolic
acidosis is related to significantly decreased values of serum IGF-I,
inhibition of hepatic IGF-I gene expression and hepatic growth hor-
mone receptors mRNA. Reduced nutritional intake may be an addi-
tional factor in the causal relationships.
Renal tubular acidosis is associated with growth retardation
in infants and children [1—8]. McSherry , Kaplan and Grumbach
[9] showed that growth hormone secretion from the pituitary is
blunted in type I renal tubular acidosis. The notion of abnormal
growth hormone secretions has recently been shown in acidotic
rats by Challa et a! [10]; however, the gene expression of
growth hormone is unknown. At this point, no data exist
concerning the effect of acidosis on insulin-like growth factors:
IGF-I, IGF-II, and the IGF binding protein-3. Nothing is known
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about the expression of hepatic IGF and growth hormone
receptor in acidosis. This study was conducted to test the
hypothesis that the growth retardation associated with non-
uremic metabolic acidosis may result from inhibition of growth
factors and of growth hormone receptor mRNA.
Methods
Male Sprague-Dawley rats were obtained from Charles River
Laboratories (Wilmington, Massachusetts, USA). Their mean
(±sD) starting weights were 165.3 8.7 g. All rats received a
standard diet (Prolab RMH 3200 meals from Agway, Inc.,
Syracuse, New York, USA) of 0.6% calcium, 0.6% phosphate
and tap water ad libitum until the beginning of the study. The
study protocol was approved by the Medical College of Vir-
ginial VCU Animal Use Committee.
Rats which were randomly assigned to the acidotic group
received ammonium chloride (1.5%) as their sole fluid intake for
eight days. The pair-fed rats were given the same food intake as
the acidotic group except that water instead of ammonium
chloride (1.5%) was provided as their fluid. The control group
ate ad libitum. On the eighth day of the study, the animals were
anesthetized with metofane and sacrificed. Blood was collected
by cardiac puncture and exsanguination. Blood acid-base status
was evaluated within 60 seconds by methods previously re-
ported [11].
Sera were immediately separated and stored at —20°C until
analysis for IGF and IGFBP could be performed by the meth-
ods of Liu, Powell and Hintz [12]. Plasma concentrations of
IGF-I and IGF-II were quantitated by radioimmunoassay (RIA)
alter Sephadex G-50 acid chromatography. The lyophilized
IGF-I fraction was reconstituted with 0.04 M phosphate buffer,
which effectively separated IGF-I from their binding proteins.
The IGF-I concentration was measured by preincubating with
anti-IGF-I antibody [UBK487, provided by Drs. L. E. Under-
wood and J. I. Van Wyk (Chapel Hill, North Carolina, USA),
through the National Hormone & Pituitary Program], for one
hour before the addition of 1251-IGF-I as the radioligand. After
an 18 hour incubation, the bound and the free radioactivity was
separated and the abundance counted. The IGF-I and -II
content was measured by the same assay procedure using
anti-IGF-II monoclonal antibody from Amano International
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Enzyme Co. (Troy, Virginia, USA), and 125!.. IGF-II as radio-
ligand. The interassay variation was
IGFBP was analyzed with Western ligand blotting as follows:
two microliters of serum sample were electrophoresed on a 12%
SDS-polyacrylamide gel under non-reducing conditions, with
prestained molecular weight markers (Bethesda Research Lab-
oratories) as standards. The size fractionated proteins were
electroblotted onto nitrocellulose. The blot was blocked, incu-
bated overnight with ['251]IGF-II, washed and dried as previ-
ously described [12]. The labeled bands of IGFBPs were
visualized by autoradiography.
The rat liver was stored in liquid nitrogen until total RNA was
probed for IGF-I by an RNA protection method [13] and
analyzed for growth hormone receptor mRNA by previously
published methods of Chan, Valerie and Chan [14]. The rat
IGF-I probe, a 376 bp Hind Ill/EcoRl fragment, in riboprobe
vector pGEM-3, was a gift from Drs. D. LeRoith and C. T.
Roberts, Jr. of the National Institutes of Health (Bethesda,
Maryland, USA). The rat growth hormone receptor probe, a
544bpHind III/bq III fragment cloned between the Hind III and
Bamhl sites of pGEM-3, was a gift from Dr. W. Baumbach of
American Cyanamid Co. (Princeton, New Jersey, USA). For
both probes, the antisense RNA synthesis, plasmid lineariza-
tion, hybridization and fragment protection methods were pre-
viously described in detail [13, 14]. The abundance of mRNA
was quantified with a densitometer (Shimadzu CS-9000, Shi-
madzu Corp., Kyoto, Japan), and the results expressed as
arbitrary densitometric units (ADU).
All data are expressed as mean SD of five animals. We
performed one factor ANOVA (Fischer test) for comparison of
values. A P value less than 0.05 was considered significantly
different.
Results
Metabolic acidosis was achieved in the five rats given 1.5%
ammonium chloride as their liquid intake. It was confirmed by
blood pH of 7.11 0.10 (mean SD) and by serum bicarbonate
concentrations of 16.7 3.0 mEq/liter. The serum bicarbonate
concentrations were significantly lower than those of the con-
trol rats (26.5 2.0 mEq/liter, P < 0.01) and of the pair-fed rats
(23.4 3.0 mEq/liter, P < 0.01). The body weights at the
beginning of the study were 167.1 3.4, 165.7 15.4 and
163.5 2.2 grams for the rats in the acidotic, pair-fed and
control groups, respectively. After one week of study protocol,
the body weights were 155.5 18.9, 156.8 19.6, and
222.9 9.7 grams for rats in the acidotic, pair-fed and control
groups, respectively. Serious growth impairment was evident in
the rats in the acidotic and pair-fed groups in comparison to rats
in the control group (P < 0.001). The mean food intake of the
acidotic rats as well as that of the pair-fed rats was 61% of the
control rats (P < 0.001).
Data for the circulating insulin-like growth factors (IGF),
IGF-binding protem-3 (IGFBP-3), hepatic IGF-I mRNA and
growth hormone receptor mRNA are summarized in Table 1.
The serum IGF-I concentrations were significantly reduced in
the rats in the pair-fed and acidotic groups as compared to the
concentrations in the control group. Although the serum IGF-II
concentrations were lower in the rats in the pair-fed and
acidotic groups, the data were not significantly different from
those in the control group. A trend may be indicated but more
Table 1. Characteristics of insulin-like growth factors (IGFs), IGF-
binding protein-3 (IGFBP), mRNA of IGF-I and growth hormone
(GH) receptor
Variables
Control Pair-fed Acidotic(N = 5) (N = 5) (N = 5)
Body weight (grown)
Serum IGF-I ng/ml
222.8 9.7 156.8 19.6 155.5 18.9
818.0 130.9a 233.6 456b 411.8
Serum IGF-II ng/ml 18.8 1ga.b 10.4 1.46 11.8 5d
IGFBP-3 ADU 11.5 9.0 10.1 2.6 11.9 6.2
Hepatic IGF-1 1.4 03b 0.6 0.26 0.9 0.36
mRNA ADU
Hepatic growth hormone 2.9 1.6 1.7 0.4 1.4 O.9'
receptor mRNA ADU
Abbreviation is: ADU, arbitrary densitometric units. Values are
presented in mean SD.
In each row values with the same superscript are not significantly
different. Different superscripts indicate different levels of statistical
significance:
a vs. b p < o.o05b vs. c p < 0.01
a d < 0.025
b vs. d P < 0.05
data are necessary to confirm the difference. The data for
IGFBP-3 in the rats in the three groups were not significantly
different, because of too much variation between samples.
The abundance of hepatic IGF mRNA scanned and the mean
(± SD) peak area in arbitrary densitometric units (ADU) were
significantly less in the acidotic rats than in the control rats (P
< 0.01) but were not different from the data in the pair-fed
group (P = 0.06). The hepatic growth hormone receptor mRNA
was significantly different at the P < 0.02 level in the rats in the
acidotic group in comparison to the rats in the control group.
Discussion
Growth retardation is a cardinal feature of non-uremic renal
tubular acidosis in children [2—8]. Many factors have been
implicated in the etiology of the growth failure in chronic
metabolic acidosis in humans [9, 10, 15] and in animals [16-19].
Data which McSherry et al [91 presented of children with renal
tubular acidosis showed a blunting of the release of growth
hormone from the pituitary in response to arginine stimulation.
More recently, by using continuous 10-minute blood samplings
from acidotic rats, we confirmed and extended their findings
[10]: as demonstrated in pair-fed animals with deconvolutional
analysis by Veldhuis, Carlson and Johnson [20], our data
indicated that the suppression of growth hormone secretion
may be influenced by food intake.
A logical sequela of these data is the examination of other
growth factors in metabolic acidosis. Because growth hormone
exerts its somatotrophic actions through IGF-I, we examined
how acidemia affects the growth hormone/insulin-like growth
factor axis, including circulating IGF-I and -II concentrations
and their binding proteins, the hepatic concentrations of IGF
mRNA and growth hormone receptor mRNA in control, aci-
dotic and pair-fed rats. Our data provide the first evidence that
non-uremic metabolic acidosis decreases IGF-I production and
that this reduction is associated with reduced IGF-I mRNA.
Because the growth hormone receptor mRNA is also affected
by acidosis, this inhibition of growth hormone induction may be
at the translational level.
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The serum concentrations of IGF-II were low in all the
animals studied in all three groups. This observation is not
surprising because IGF-II has been shown to be an intrauterine
growth factor [21] with its effects taken over after birth by
IGF-I.
IGF binding protein-3 (IGFBP-3) is the principal extrauterine
serum IGF binding protein and has been considered a growth
inhibitor [22]. The other IGFSPs are present in miniscule
concentrations and do not contribute significantly to the serum
IGF binding protein pool [22]. IGFBP-3 exists in forms of low
molecular weight (25 to 35 kD) and high molecular weight (38
and 41 kD). It usually binds IGF to an acid-labile subunit to
form a complex weighing 150 kD. In uremia, IGFBP-3 is
elevated mainly through an increase in the low molecular
weight fractions [22], The serum concentrations of IGFBP-3 in
acidosis are no different from the normal state. Our data do not
support a significant role for acidosis on IGFBP-3.
Although I ,25-dihydroxyvitamin D was not measured in this
study, if IGF-I stimulates I ,25-dihydroxyvitamin D production,
as suggested by the data of Nesbitt and Drezner [23], then the
suppressed IGF-I production seen in our study is commensu-
rate with I ,25-dihydroxyvitamin D inhibition secondary to
acidosis. The degree of acidosis may also have a bearing on the
inhibition of the renal la-hydroxylase system. In rat experi-
ments, the degree of acidosis is usually more severe than in
volunteers made acidotic with ammonium chloride ingestion or
in patients with renal tubular acidosis. Thus, the inhibition of
1 ,25-dihydroxyvitamin-D production is more profound in the
severe acidosis of animal experiments. Salt wasting, a common
component of renal tubular acidosis, is not addressed in our
animal model. However, we should recognize that the ammo-
nium chloride metabolic acidosis has been the animal model for
non-uremic acidosis for the last three decades.
Recent preliminary data by Friedman et al [24] and Choba-
nian et al [19] demonstrated that if food intake was limited, the
administration of recombinant human growth hormone was not
effective in overcoming the growth inhibition in ammonium
chloride acidotic weanling rats. This emphasizes the impor-
tance of poor nutrition as an inhibitor of linear growth. Our data
show a significant inhibition of hepatic growth hormone recep-
tor mRNA in acidotic rats as compared to control rats (P <
0.025). The pair-fed rats show a downward trend, but this
inhibition is less pronounced than in the rats of the acidotic
group. The data did not reach statistical significance. Thus, our
data suggest that the reduced food intake inhibits growth
hormone receptor gene expression but not to the same degree
as acidosis and provide a possible mechanism for the growth
failure. This corroborates earlier data by Philipps et al [25]
which showed that calorie limitation in neonatal rats reduced
IGF-I and -II in serum, liver and brain accompanied with a rise
of serum binding proteins [25]. They speculated that the de-
pressed growth during a period of calorie restriction was a
protective mechanism for the animal.
In studies by Straus and Takemoto [26], the effects of four
isocaloric diets containing 20%, 12%, 8% and 4% protein on
IGF-I and hepatic IGF-I mRNA were evaluated in young
growing rats. These investigators showed that a decrease in
growth on the 4% protein diet was associated with decreased
serum IGF-I and decreased abundance of hepatic IGF-I
mRNA. The equal suppression of IGF gene expression in our
pair-fed animals suggests a causal relationship among food
intake, IGF gene expression and growth.
In summary, our data show that the hepatic IGF-l mRNA is
significantly inhibited by metabolic acidosis. This inhibition
appears to be dependent, to some degree, on nutritional intake
because the pair-fed rats show similar hepatic IGF- 1 mRNA
concentrations. Finally, the growth hormone receptor mRNA is
inhibited by acidosis. Thus, we conclude that the growth
retardation seen with metabolic acidosis is brought about, in
part, by the decreased growth hormone secretion [7, 10] and
further aggravated via inhibition of IGF-I mRNA, by the
significant decrease in circulating IGF-I and growth hormone
receptor mRNA.
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